![](/media/zbvh5m1w/5_media-center-v3.jpg?anchor=center&mode=crop&width=1920&height=1080&rnd=133052059406670000)
Media Center
Filter by:
December 05, 2022
Ninerafaxstat to Provide Optimal Ventricular Energetics in HCM: IMPROVE-HCM
August 26, 2022
IMPROVE DiCE: A Phase 2a Trial Investigating Ninerafaxstat - A Novel Cardiac Mitotrope for the treatment of Diabetic Cardiomyopathy
July 05, 2021
IMB-10189721, a novel first-in-class partial fatty acid oxidation (pFOX) inhibitor improves cardiac remodelling and function post-myocardial infarction.
July 05, 2021